Jefferies Keeps Their Buy Rating on Teva Pharmaceutical (TEVA)
In a report released today, Glen Santangelo from Jefferies maintained a Buy rating on Teva Pharmaceutical (TEVA – Research Report), with ...
Insider Monkey14d
Jim Cramer on Zoetis Inc. (ZTS): ‘I Like It Very Much’
In this article, we are going to take a look at where Zoetis Inc. (NYSE:ZTS) stands against Jim Cramer’s other stock picks. In a recent episode of Mad Money, Jim Cramer views the current market ...
Stockhouse14d
Zoetis Inc Is Being Looked Into For Possibly Defrauding Shareholders And The Schall Law Firm Seeks The Public's Assistance
LOS ANGELES, CA / ACCESSWIRE / September 5, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Zoetis Inc. ( ...
Stockhouse16d
The Schall Law Firm Is Investigating Whether Zoetis Inc. Violated Securities Laws And Investors Can Lend A Hand
LOS ANGELES, CA / ACCESSWIRE / September 4, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Zoetis Inc. ( ...
Business Insider24d
Stifel Nicolaus Reaffirms Their Buy Rating on Zoetis (ZTS)
Stifel Nicolaus analyst Jonathan Block maintained a Buy rating on Zoetis (ZTS – Research Report) today and set a price target of $200.00. The company’s shares closed yesterday at $181.56.